In vivo drug movement is often regulated by multiple transporter interactions. Dr. Huang shares his perspectives on how transporters orchestrate complex drug transport phenomena.
Download the recording for this webinar and you will:
- Learn the best methods to incorporate transporter research into the drug discovery process
- See examples of how multi-transporter models can predict in vivo effects
Dr. Yong Huang, Ph.D.
Dr. Huang is an entrepreneur and innovator with nearly 20 years of experience in moving novel ideas to the marketplace. He founded Optivia Biotechnology, now a BioIVT company, the industry’s leading transporter research solution provider serving nearly 500 clients worldwide over the last decade. Dr. Huang is an internationally recognized thought-leader in transporter-related drug discovery and development. He is the principal investigator for nearly $8 million in NIH and FDA research grants and is the co-inventor and co-author of numerous patents, peer-reviewed articles and conference presentations.